Financial Statements and Highlights | Takeda Investor Relations

glasses laying on a book with stock options

Financial Highlights

Loading feed metadata...

Stay up to date on financial results, corporate milestones and learn how we're delivering on our commitment to patients, our people and the planet

Recent News

Takeda’s Dengue Vaccine Recommended by World Health Organization Advisory Group for Introduction in High Dengue Burden and Transmission Areas in Children Ages Six to 16 Years

October 3, 2023

Takeda Provides Update on EXKIVITY® (mobocertinib)

October 2, 2023

Takeda Announces Amendment of Compensation Recoupment Policy

October 2, 2023

U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Ulcerative Colitis

September 27, 2023

Explore

Investor Events

Access our IR events calendar and recaps of past events

Our Pipeline

Learn more about our dynamic and diverse pipeline